Systematic Lupus Erythematosus (SLE)

You may qualify to participate if you:

  • Are willing and able to provide written informed consent
  • Are willing and able to provide appropriate photo identification
  • Are 18 years of age or over
  • Have been diagnosed with systematic lupus erythematosus (SLE)
  • Live in the Boston Area

You may not qualify to participate if you:

  • Have a known history of HIV or hepatitis virus
  • Have concurrent and serious medical conditions such as a class III or IV heart failure according to the New York Heart Association
  • Have a diagnosis of psychiatric illness that requires current treatment
  • Have serious complications from lupus such as cerebral lupus or catastrophic anti-phospholipid syndrome
  • Have severe active infections such as urinary tract infections
  • Have been diagnosed or treated for any malignancy within 3 years of study enrollment
  • Have an active use of drug culpritis implicated in etiology of SLE such as hydralazine,  procainamide, quinidine, isoniazid, diltitazem, and minocycline
  • Had any treatment with any of the following drugs within the last year: cyclophosphamide, rituximab, belimumab, atacicept, any anti-BlyS, or abatacept
  • Are pregnant

As a thank you for your time, we will provide you with a $50 deposit on a MasterCard gift card for each home visit. The balance will be available to you within 24 hours of your appointment. You can use this card wherever MasterCard is accepted.

Email: study@sanguinebio.com

Phone: 855.836.4759 (Option 1)

Hours: Monday – Friday, 8am to 5pm PST

Systematic Lupus Erythematosus (SLE)

We are currently seeking patients with systematic lupus erythematosus (SLE) to donate a small sample of blood from the comfort of their own home.

The goal of this study is to identify biomarkers in the blood of systematic lupus erythematosus (SLE) patients that may be used to develop better diagnostics and treatments for systematic lupus erythematosus (SLE) .

The Moral Behind Our Story

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We believe it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel.

Our mobile staff covers the US, Canada and parts of Europe. Each staff member is trained on study specific protocols and carries the credentials necessary to conduct clinical trial procedures in the patient’s home.

The Key to Success is Swiftness

Once you sign up, we will review your health profile and contact you if you might qualify for a research study. If you may qualify for a study, a clinical research coordinator will contact you within 48 hours to confirm your health information and tell you more about what is required to participate in a certain study.

When you are ready to be scheduled, your clinical research coordinator will work with you to schedule an at­-home visit. One of Sanguine’s mobile health staff members will meet you in the privacy and comfort of your home to explain the research study and perform the blood collection.